CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Adjusts Price Target on Cytokinetics to $112 From $106, Maintains Buy Rating

Positive
AI Analysis

Summary

Truist increased its price target on Cytokinetics to $112 from $106 while maintaining a Buy rating, reflecting a modest upward adjustment to the analyst's valuation.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 10, 2026 10:11 AM

Read Original